CellSeed Company
%20.jpg)
CellSeed develops regenerative medicine products primarily in Japan and Europe.
Founded Date:
2001-01-01
Last Funding Type:
Post-IPO Equity
Headquarters:
Japan
Investors Number:
16
Technology:
Regenerative Medicine
Employee Number:
11-50
Industry:
Alternative Medicine, Health Care, Market Research
Estimated Revenue:
Less than $1M
Last Funding Date:
41702
Funding Status:
IPO
Investor Type:
For Profit
Total Funding:
3167328000